Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

News Conference News TCT 2020

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

Todd Neale

October 21, 2020

News Conference News TCT 2020

STEMI Door-to-Balloon Times Haven’t Suffered During COVID-19: NACMI

Caitlin E. Cox

October 14, 2020

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

News Conference News TCT 2017

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

Michael O'Riordan

October 30, 2017

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

Presentation TCT 2014

Thoughtful Insights

Presenter: Neal S. Kleiman

September 17, 2014

Presentation TCT 2014

Case Presentation

Presenter: Frederick Kushner

September 17, 2014

News Conference News TCT 2013

CHILL-MI: Therapeutic Hypothermia Most Effective in Early Anterior STEMI

October 30, 2013

Presentation TCT 2013

Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Presenter: A. Rene, Philippe Genereux, Michael Ezekowitz, Ajay Kirtane, Roxana Mehran, Gregg Stone

January 31, 2013

Presentation TCT 2012

Case 4: The Patient with Atrial Fibrillation Presenting with an Acute Coronary Syndrome

Presenter: Michael Ezekowitz

October 24, 2012

Presentation TCT 2012

Strategies for the ACS Patient with Chronic Atrial Fibrillation

Presenter: C. Michael Gibson

October 24, 2012

Presentation TCT 2012

TCT-62. Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Presenter: A. Rene

October 23, 2012

Advertisement

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Icosapent Ethyl’s Benefits Consistent in Patients With Prior PCI: REDUCE-IT

STEMI Door-to-Balloon Times Haven’t Suffered During COVID-19: NACMI

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

No Late Quality of Life Trade-offs With PCI in Left Main Disease: EXCEL-QOL Substudy

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Thoughtful Insights

Case Presentation

CHILL-MI: Therapeutic Hypothermia Most Effective in Early Anterior STEMI

Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Case 4: The Patient with Atrial Fibrillation Presenting with an Acute Coronary Syndrome

Strategies for the ACS Patient with Chronic Atrial Fibrillation

TCT-62. Impact of Atrial Fibrillation in Patients with STEMI Before and After Primary PCI: Insights from the HORIZONS-AMI Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content